Multidisciplinary cardiac case conference

Multidisciplinary cardiac case conference has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Oct 26, 2026: “Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations”.

Exposure

1 paper studies it4 findingsUpdated

1 new paper in 30 daysSee all 1 papers on multidisciplinary cardiac case conference

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Quadruple therapy increased from 45% to 82% (p<0.001).”
Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populationsESC Congress 2026 abstract2026doi:10.1093/eurheartj/ehag785.1372

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans1

What did studies of multidisciplinary cardiac case conference find?

4

Studies of multidisciplinary cardiac case conference measured 4 outcomes, among them medication safety outcomes, renal function and left ventricular ejection fraction.

Medication safety outcomes

no changein humans1

1 study
  1. Multidisciplinary cardiac case conference was not clearly linked with medication safety outcomes in humans (heart failure with reduced ejection fraction).

    “There was no significant change in hyperkalaemia, renal dysfunction nor admissions related to medication side effects.”

    Humansheart failure with reduced ejection fractionn = 89

    Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations

    ESC Congress 2026 abstract

Renal function

no changein humans1

1 study
  1. Multidisciplinary cardiac case conference was not clearly linked with renal function in humans (eGFR <45) (GFR +0.3; units not stated).

    “Patients with eGFR <45 (n=27) had stable renal function (GFR +0.3, p=0.87)”

    HumanseGFR <45kidneyn = 27

    Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations

    ESC Congress 2026 abstract

Left ventricular ejection fraction

upin humans1

1 study
  1. Multidisciplinary cardiac case conference is linked with higher left ventricular ejection fraction in humans (heart failure with reduced ejection fraction) (+12.1±10.8%).

    “Mean LVEF improved +12.1±10.8% (p<0.001)”

    Humansheart failure with reduced ejection fractionleft ventriclen = 89

    Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations

    ESC Congress 2026 abstract

More on Left ventricular ejection fraction

Quadruple therapy achievement

upin humans1

1 study
  1. Multidisciplinary cardiac case conference is linked with higher quadruple therapy achievement in humans (heart failure with reduced ejection fraction) (45% to 82%).

    “Quadruple therapy increased from 45% to 82% (p<0.001).”

    Humansheart failure with reduced ejection fractionn = 89

    Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations

    ESC Congress 2026 abstract

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months